GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Curiox Biosystems Co Ltd (XKRX:445680) » Definitions » Intangible Assets

Curiox Biosystems Co (XKRX:445680) Intangible Assets : ₩35,981 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Curiox Biosystems Co Intangible Assets?

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Curiox Biosystems Co's intangible assets for the quarter that ended in Dec. 2024 was ₩35,981 Mil.


Curiox Biosystems Co Intangible Assets Historical Data

The historical data trend for Curiox Biosystems Co's Intangible Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curiox Biosystems Co Intangible Assets Chart

Curiox Biosystems Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Intangible Assets
Get a 7-Day Free Trial 31,015.51 32,112.14 33,494.16 33,602.51 35,980.98

Curiox Biosystems Co Quarterly Data
Dec19 Dec20 Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Intangible Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33,602.51 34,039.95 34,610.28 34,580.83 35,980.98

Curiox Biosystems Co Intangible Assets Calculation

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Examples of intangible assets include trade secrets, copyrights, patents, trademarks. If a company acquires assets at the prices above the book value, it may carry goodwill on its balance sheet. Goodwill reflects the difference between the price the company paid and the book value of the assets.


Curiox Biosystems Co  (XKRX:445680) Intangible Assets Explanation

If a company (company A) received a patent through their own work, though it has value, it does not show up on its balance sheet as an intangible asset. However, if company A sells this patent to company B, it will show up on company B's balance sheet as an intangible asset.

The same applies to brand names, trade secrets etc. For instance, Coca-Cola's brand is extremely valuable, but the brand does not appear on its balance sheet, because the brand was never acquired.

Some intangibles are amortized. Amortization is the depreciation of intangible assets.

Many intangibles are not amortized. They may still be written down when the company decides the asset is impaired.

Whenever you see an increase in goodwill over a number of years, you can assume it's because the company is out buying other businesses above book value. GOOD if buying businesses with durable competitive advantage.

If goodwill stays the same, the company when acquiring other companies is either paying less than book value or not acquiring. Businesses with moats never sell for less than book value.

Intangibles acquired are on balance sheet at fair value.

Internally developed brand names (Coke, Wrigleys, Band-Aid) however are not reflected on the balance sheet.

One of the reasons competitive advantage power can remain hidden for so long.


Be Aware

Companies may change the way intangible assets are amortized, and this will affect their reported earnings.


Curiox Biosystems Co Intangible Assets Related Terms

Thank you for viewing the detailed overview of Curiox Biosystems Co's Intangible Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Curiox Biosystems Co Business Description

Traded in Other Exchanges
N/A
Address
Samsung Harrington IT Tower, 204-213, 202, 2nd Floor, 9 Gil 41 Digital-Ro, Geumchun-Gu, Seoul, KOR, 08511
Curiox Biosystems Co Ltd is Korean Based company which brings together decades of scientific and engineering expertise in surface chemistry and life science instrumentation with the goal of overcoming critical challenges that slow the pace of life science research. The company has introduced Laminar Wash technology, which automates cell processing and enables highly reproducible and high-throughput cell analysis. The company offers various products such as LAMINAR WASH AUTO 1000 SYSTEM, Curiox Laminar Wash HT2000 System and Laminar Wash MINI System.

Curiox Biosystems Co Headlines

No Headlines